Stocks Explorer
Stocks
Sectors
Search
Innate Pharma S.A(IDD) News
Profile
Chart
News
Analysis
IDD price today
by TradingView
Date
Title
Feb 17
Innate Pharma Announces U.S. FDA Granted Breakthrough Therapy Designation to Lacutamab for Relapsed or Refractory Sézary Syndrome
‹ Prev
Page
of 1
Next ›